Pfizer Expects Speedy Integration Of Wyeth, R&D Head Mackay Says

Pfizer's integration of Wyeth will progress much faster than previous integrations, with "significant announcements" expected within 30 to 60 days after the deal closes, Global R&D Head Martin Mackay said Sept. 22 during Windhover's Pharmaceutical Strategic Alliance Conference in New York City

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet